SEC Comment Letter for SPECTRUM PHARMACEUTICALS INC (CIK 0000831547) — Jul 19, 2021
SPECTRUM PHARMACEUTICALS INC (CIK 0000831547)
Date: July 19, 2021 · CIK: 0000831547 · Accession: 0000000000-21-008891
AI Filing Summary & Sentiment
File numbers found in text: 333-257876
Letter
United States securities and exchange commission logo July 19, 2021 Kurt Gustafson Chief Financial Officer Spectrum Pharmaceuticals, Inc. 11500 South Eastern Avenue, Suite 240 Henderson, Nevada 89052 Re:Spectrum Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed July 13, 2021 File No. 333-257876 Dear Mr. Gustafson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Laura Crotty at 202-551-7614 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Teri O'Brien
Show Raw Text
United States securities and exchange commission logo
July 19, 2021
Kurt Gustafson
Chief Financial Officer
Spectrum Pharmaceuticals, Inc.
11500 South Eastern Avenue, Suite 240
Henderson, Nevada 89052
Re:Spectrum Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed July 13, 2021
File No. 333-257876
Dear Mr. Gustafson:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Laura Crotty at 202-551-7614 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Teri O'Brien